Tỷ lệ sống sót và các yếu tố tiên lượng ở bệnh nhân ung thư đại trực tràng bên phải và bên trái giai đoạn I–IV: một nghiên cứu hồi cứu tại một trung tâm chưa lựa chọn

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F (2019) Estimating the global cancer incidence and mortality in, (2018) GLOBOCAN sources and methods. Int J Cancer 144:1941–1953. https://doi.org/10.1002/ijc.31937

Mostafa G, Matthews BD, Norton HJ, Kercher KW, Sing RF Heniford BT (2004) Influence of demographics on colorectal cancer in: Am Surg 259–264

Miller A, Gorska M, Bassett M (2000) Proximal shift of colorectal cancer in the Australian Capital Territory over 20 years. Aust N Z J Med 30:221–225. https://doi.org/10.1111/j.1445-5994.2000.tb00811.x

Nawa T, Kato J, Kawamoto H, Okada H, Yamamoto H, Kohno H, Endo H, Shiratori Y (2008) Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol 23:418–423. https://doi.org/10.1111/j.1440-1746.2007.04923.x

Shen H, Yang J, Huang Q, Jiang MJ, Tan YN, Fu JF, Zhu LZ, Fang XF, Yuan Y (2015) Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol 21:6470–6478. https://doi.org/10.3748/wjg.v21.i21.6470

Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B (2000) Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355:1745–1750. https://doi.org/10.1016/S0140-6736(00)02261-3

Khatri VP, Chee KG, Petrelli NJ (2007) Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 16:71–83. https://doi.org/10.1016/j.suronc.2007.05.001

Missiaglia E, Jacobs B, D’Ario G, Di Narzo AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan P, Roth AD, Klingbiel D, Bosman FT, Delorenzi M, Tejpar S (2014) Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol 25:1995–2001. https://doi.org/10.1093/annonc/mdu275

Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61:847–854. https://doi.org/10.1136/gutjnl-2011-300865

Stintzing S, Tejpar S, Gibbs P, Thiebach L, Lenz HJ (2017) Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes. Eur J Cancer 84:69–80. https://doi.org/10.1016/j.ejca.2017.07.016

Petrelli F, Tomasello G, Borgonovo K, Ghidini M, Turati L, Dallera P, Passalacqua R, Sgroi G, Barni S (2017) Prognostic survival associated with left-sided vs right-sided colon cancer a systematic review and meta-analysis. JAMA Oncol 3:211–219. https://doi.org/10.1001/jamaoncol.2016.4227

Yahagi M, Okabayashi K, Hasegawa H, Tsuruta M, Kitagawa Y (2016) The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg 20:648–655. https://doi.org/10.1007/s11605-015-3026-6

Hansen IO, Jess P (2012) Possible better long-term survival in left versus right-sided colon cancer - a systematic review, Dan Med J 59

Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N (2008) Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 15:2388–2394. https://doi.org/10.1245/s10434-008-0015-y

Mejri N, Dridi M, El Benna H, Labidi S, Daoud N, Boussen H (2018) Tumor location impact in stage II and III colon cancer: epidemiological and outcome evaluation. J Gastrointest Oncol 9:263–268. https://doi.org/10.21037/jgo.2017.12.02

Warschkow R, Sulz MC, Marti L, Tarantino I, Schmied BM, Cerny T, Güller U (2016) Better survival in right-sided versus left-sided stage I - III colon cancer patients, BMC Cancer 16. https://doi.org/10.1186/s12885-016-2412-0

Ishihara S, Murono K, Sasaki K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Sugihara K, Watanabe T (2018) Impact of primary tumor location on postoperative recurrence and subsequent prognosis in nonmetastatic colon cancers. Ann Surg 267:917–921. https://doi.org/10.1097/sla.0000000000002206

Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens J-H, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740. https://doi.org/10.1056/nejmoa040694

Rosenblum JD, Boyle CM, Schwartz LB (1997) The mesenteric circulation. Surg Clin North Am 77:289–306. https://doi.org/10.1016/s0039-6109(05)70549-1

Chirurgie des Kolonkarzinoms (2021) https://doi.org/10.1007/978-3-662-60453-3

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae

Brenner H, Kloor M, Pox CP (2014) Colorectal cancer, in: Lancet 1490–1502. https://doi.org/10.1016/S0140-6736(13)61649-9.

Mik M, Berut M, Dziki L, Trzcinski R, Dziki A (2017) Right-and left-sided colon cancer-clinical and pathological differences of the disease entity in one organ. Arch Med Sci 13:157–162. https://doi.org/10.5114/aoms.2016.58596

Weiss JM, Pfau PR, O’Connor ES, King J, LoConte N, Kennedy G, Smith MA (2011) Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-medicare data. J Clin Oncol 29:4401–4409. https://doi.org/10.1200/JCO.2011.36.4414

Yang J, Du XL, Li ST, Wang BY, Wu YY, Chen ZL, Lv M, Shen YW, Wang X, Dong DF, Li D,  Wang F, Li EX, Yi M, Yang J (2016) Characteristics of differently located colorectal cancers support proximal and distal classification: a population-based study of 57,847 patients, PLoS One 11. https://doi.org/10.1371/journal.pone.0167540

Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, Wexner S, Givel JC, Belin B (2001) Dukes B colerectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum 44:364–373. https://doi.org/10.1007/bf02234734

Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H (2010) Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 53:57–64. https://doi.org/10.1007/DCR.0b013e3181c703a4

Derwinger K, Gustavsson B (2011) Variations in demography and prognosis by colon cancer location. Anticancer Res 31:2347–2350

Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Hata K, Nozawa H, Kanazawa T, Kazama S, Yamaguchi H, Sunami E, Kitayama J, Hashiguchi Y, Sugihara K, Watanabe T (2014) Prognostic impact of tumor location in stage IV colon cancer: a propensity score analysis in a multicenter study. Int J Surg 12:925–930. https://doi.org/10.1016/j.ijsu.2014.07.270

Mayanagi S, Kashiwabara K, Honda M, Oba K, Aoyama T, Kanda M, Maeda H, Hamada C, Sadahiro S, Sakamoto J, Saji S, Yoshikawa T (2018) Risk factors for peritoneal recurrence in stage II to III colon cancer. Dis Colon Rectum 61:803–808. https://doi.org/10.1097/DCR.0000000000001002

Catalano V, Loupakis F, Graziano F, Bisonni R, Torresi U, Vincenzi B, Mari D, Giordani P, Alessandroni P, Salvatore L, Fornaro L, Santini D, Baldelli AM, Rossi D, Giustini L, Silva RR, Falcone A, D’emidio S, Rocchi M, Luzi Fedeli S (2012) Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer, Ann Oncol 23:135–141. https://doi.org/10.1093/annonc/mdr062

Ott C, Gerken M, Hirsch D, Fest P, Fichtner-Feigl S, Munker S, Schnoy E, Stroszczynski C, Vogelhuber M, Herr W, Evert M, Reng M, Schlitt HJ, Klinkhammer-Schalke M, Teufel A (2018) Advanced mucinous colorectal cancer: epidemiology, prognosis and efficacy of chemotherapeutic treatment. Digestion 98:143–152. https://doi.org/10.1159/000487710

Öhman U (1982) Prognosis in patients with obstructing colorectal carcinoma. Am J Surg 143:742–747. https://doi.org/10.1016/0002-9610(82)90050-2

Sjo OH, Larsen S, Lunde OC, Nesbakken A (2009) Short term outcome after emergency and elective surgery for colon cancer. Color Dis 11:733–739. https://doi.org/10.1111/j.1463-1318.2008.01613.x

Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, Colquhoun K (1985) A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72:698–702. https://doi.org/10.1002/bjs.1800720909

Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, Ballario E, Becchi G, Bonilauri S, Carobbi A, Cavaliere P, Garcea D, Giuliani L, Morziani E, Mosca F, Mussa A, Pasqualini M, Poddie D, Tonetti F, Zardo L, Rosso R (2002) Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy. Ann Surg 235:458–463. https://doi.org/10.1097/00000658-200204000-00002

Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, Wolff RK, Slattery ML (2005) Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 65:6063–6070. https://doi.org/10.1158/0008-5472.CAN-05-0404

Taieb J, Le Malicot K, Shi Q, Lorca FP, Bouché O, Tabernero J, Mini E, Goldberg RM,  Folprecht G, Van Laethem JL, Sargent DJ, Alberts SR, Emile JF, Puig PL, Sinicrope FA (2017) Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer, J Natl Cancer Inst 109. https://doi.org/10.1093/jnci/djw272

Kamphues C, Kadowaki S, Amini N, van den Berg I, Wang J, Andreatos N, Sakamoto Y, Ogura T, Kakuta M, Pikouli A, Geka D, Daitoku N, Theochari M, Buettner S, Akiyama T, Antoniou E, Pikoulis E, Theodoropoulos G, Imai K, Ijzermans JNM, Margonis GA, Akagi K, Kreis ME (2021) The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: an international, multi-institutional study in patients with known KRAS, BRAF, and MSI status. J Surg Oncol 123:1005–1014. https://doi.org/10.1002/jso.26352

Dronkers JJ, Lamberts H, Reutelingsperger IMMD, Naber RH, Dronkers-Landman CM, Veldman A, Van Meeteren NLU (2010) Preoperative therapeutic programme for elderly patients scheduled for elective abdominal oncological surgery: a randomized controlled pilot study. Clin Rehabil 24:614–622. https://doi.org/10.1177/0269215509358941

Burden ST, Hill J, Shaffer JL, Campbell M, Todd C (2011) An unblinded randomised controlled trial of preoperative oral supplements in colorectal cancer patients. J Hum Nutr Diet 24:441–448. https://doi.org/10.1111/j.1365-277X.2011.01188.x

Paine H, Chand M (2020) Lymph node harvesting in colorectal cancer: the role of fluorescence lymphangiography, in: Video Atlas Intraoperative Appl. Near Infrared Fluoresc. Imaging 171–182. https://doi.org/10.1007/978-3-030-38092-2_20.